Home > Newsletters > FDAnews Device Daily Bulletin > FDA Cites Calif. LapBand Clinic on Misleading Commercials, Billboards
FDAnews Device Daily Bulletin
Aug. 2, 2012 | Vol. 9 No. 151
FDA Cites Calif. LapBand Clinic on Misleading Commercials, Billboards
Los Angeles weight-loss surgery clinic Lap-Band VIP has received an FDA warning letter for misleading marketing claims. According to the June 25 letter, the clinic misbranded the LapBand device in two television commercials and two billboards by not revealing risk information or requirements to qualify for the LapBand surgery, the June 25 letter states. The letter was recently posted to the FDA website.
Devices & Diagnostics Letter
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.